Aspire BioPharma, Inc. (ASBP) — Capital Reinvestment Ratio
Latest as of December 2024:
0.00x
Aspire BioPharma, Inc. (ASBP) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($479.57K) in capital expenditures ($4.00). Check how tangible is Aspire BioPharma, Inc.'s equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$479.57K
USD
Capital Expenditures
$4.00
USD
Data as of
Dec 2024
Most recent filing
Annual Capital Reinvestment Ratio for Aspire BioPharma, Inc. (None–None)
Year-by-year Capital Reinvestment Ratio for Aspire BioPharma, Inc. from None to None. See Aspire BioPharma, Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow